Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of QVA149 on Lung Function and Gas Exchange in COPD
NCT02634983Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Jun 2016; status: completed.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02634983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634983.